These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19177582)

  • 1. Revisiting the treatment recommendations for chronic hepatitis B.
    Chan HL
    Hepatology; 2009 Feb; 49(2):700; author reply 701-2. PubMed ID: 19177582
    [No Abstract]   [Full Text] [Related]  

  • 2. [Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].
    Bronowicki JP; Barraud H; Couzigou P
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S17-9. PubMed ID: 17075490
    [No Abstract]   [Full Text] [Related]  

  • 3. [Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2006 Nov; 14(11):836-7. PubMed ID: 17125613
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential combination therapy for chronic hepatitis B: more challenges to be tackled.
    Tseng TC; Liu CJ; Kao JH
    Am J Gastroenterol; 2007 Jul; 102(7):1544; author reply 1545. PubMed ID: 17593169
    [No Abstract]   [Full Text] [Related]  

  • 5. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 6. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
    Wiegand J; Patel K; Tillmann HL
    Hepatology; 2009 Oct; 50(4):1314; author reply 1314. PubMed ID: 19676132
    [No Abstract]   [Full Text] [Related]  

  • 7. Do guidelines preclude hepatitis B patients from receiving treatment?
    Degertekin B; Lok AS
    Hepatology; 2009 Feb; 49(2):700-1; author reply 701-2. PubMed ID: 19177583
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hepatitis B: who, when, and how?
    Wong SN; Lok AS
    Arch Intern Med; 2006 Jan; 166(1):9-12. PubMed ID: 16401805
    [No Abstract]   [Full Text] [Related]  

  • 9. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.
    Zoulim F
    J Hepatol; 2005 Mar; 42(3):302-8. PubMed ID: 15710212
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
    Dai CY; Chuang WL; Huang JF; Yu ML
    Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
    MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
    [No Abstract]   [Full Text] [Related]  

  • 12. [New recommendations about treatment of chronic virus hepatitis of Asian-Pacific Association for Studying the Liver (APASL): what changed in 2008?].
    Isakov VA
    Eksp Klin Gastroenterol; 2008; (6):114-5. PubMed ID: 19334435
    [No Abstract]   [Full Text] [Related]  

  • 13. [Up-to-date algorithms for diagnosis and treatment of chronic hepatitis B].
    Maev IV; Polunina TE; Polunina EV
    Klin Med (Mosk); 2009; 87(8):7-12. PubMed ID: 19827522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An omission in the AASLD Practice Guidelines on Chronic Hepatitis B.
    Jhaveri R; Murray N
    Hepatology; 2007 Jul; 46(1):280; author reply 280. PubMed ID: 17596892
    [No Abstract]   [Full Text] [Related]  

  • 15. Is entecavir ideal for the treatment of lamivudine-refractory chronic hepatitis B?
    Su CW; Wu JC; Lee SD
    Hepatology; 2008 Nov; 48(5):1726-7; author reply 1727-8. PubMed ID: 18972445
    [No Abstract]   [Full Text] [Related]  

  • 16. AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy.
    Stroffolini T; Gaeta GB; Mele A
    Hepatology; 2007 Aug; 46(2):608-9; author reply 609. PubMed ID: 17661422
    [No Abstract]   [Full Text] [Related]  

  • 17. Conclusion to 'Hepatitis B virus heterogeneity--a means to personalized care'.
    Bonino F;
    Antivir Ther; 2010; 15 Suppl 3():79-80. PubMed ID: 21041907
    [No Abstract]   [Full Text] [Related]  

  • 18. [To the contribution by Claus Niederau. New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].
    Lelgemann M; Ollenschläger G
    Med Klin (Munich); 2007 Sep; 102(9):761-2. PubMed ID: 17879014
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of HIV-HBV-coinfection].
    Mauss S
    MMW Fortschr Med; 2009 Apr; 151(18):49-50, 52-3. PubMed ID: 19769076
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for and treating hepatitis B virus in patients with HIV infection.
    Tillmann HL
    Clin Infect Dis; 2007 Sep; 45(5):633-6. PubMed ID: 17683000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.